📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $182.06897
- Sector: Healthcare – Drug Manufacturers – General
💡 The Growth Thesis
Buy Consensus: Biogen Inc. Analysts project a 3.5% potential upside. Currently trading at a Forward P/E of 11.564952.